Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

zanthoxylum nitidum tincture

PreclinicalSmall molecule

GGuangzhou University of Traditional Chinese Medicine

zanthoxylum nitidum tincture is one of 2 small molecule programs targeting Paronychia. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

ParonychiaActive, not recruiting

ParonychiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

1 competitor in Paronychia

#DrugCompanyPhaseTrials

Achromycin V

WWyeth-Lederle Vaccines

zanthoxylum nitidum tincture

GGuangzhou University of Traditional Chinese Medicine

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Paronychia1 trial

Effect of Zanthoxylum Nitidum Tincture for Paronychia Caused by Afatinib

Unknown status·GGuangzhou University of Traditional Chinese Medicine·N/A·NCT03908892·110 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for zanthoxylum nitidum tincture. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — zanthoxylum nitidum tincture compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for zanthoxylum nitidum tincture. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Guangzhou University of Traditional Chinese Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GGuangzhou University of Traditional Chinese Medicine

Related News